Low intake of ultra-processed foods regularly may raise diabetes, cancer risk
The study showed that low but regular intake of processed meat, sugar-sweetened beverages (SSBs), and trans fatty acids (TFAs) can increase the risk of diseases like Type 2 diabetes, ischemic heart disease (IHD), and colorectal cancer.
While the risks have long been known, systematic characterisation of the dose-response relationships between these foods and health outcomes is limited, said the researchers from the Institute for Health Metrics and Evaluation at the University of Washington.
In the paper published in the journal Nature Medicine, the team showed that consumption of processed meat between 0.6 grams and 57 grams daily can raise the risk of type 2 diabetes by at least 11 per cent compared with no consumption.
For colorectal cancer, the risk was 7 per cent higher for consumption between 0.78 grams per day and 55 grams per day. The relative risk of IHD was estimated at 1.15 at 50 grams per day intake.
Further, an intake of sugar-sweetened beverage intake between 1.5 and 390 grams daily was found to raise the average risk of type 2 diabetes by 8 per cent.
Intake between 0 and 365 grams per day was associated with a 2 per cent higher average risk of IHD.
'The new analysis supports dietary guidelines to reduce the consumption of processed meat, sugar-sweetened beverages and trans-fatty acids -- highlighting the need for a collaborative, meticulous health assessment framework for ultra-processed foods,' said the researchers in the paper.
The findings showed that the risk increased continuously at every level of consumption, with the steepest increases occurring at low habitual intake, approximately equivalent to one serving or less daily.
Several previous studies have linked ultra-processed foods, particularly processed meats, sugar-sweetened beverages, and trans fatty acids, with elevated chronic disease risks.
Estimates suggest that diets high in processed meat contributed to nearly 300,000 deaths worldwide in 2021, while diets rich in sugar-sweetened beverages and trans fats accounted for millions of disability-adjusted life years.
It is because processed meats preserved through smoking, curing, or chemical additives often contain compounds such as N-nitroso agents, polycyclic aromatic hydrocarbons, and heterocyclic amines -- compounds implicated in tumour development, explained the researchers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
First Post
11 hours ago
- First Post
Billionaire-backed team planned massive test planned a test to dim sunlight: Here's how it turned out
The multimillion-dollar project would have produced clouds over a stretch of ocean larger than Puerto Rico. The initial experiment was intended to run for months read more People watch the sunset over the Rio Negro in Manaus, Amazonas state, Brazil on July 6, 2025. AFP/Representational image A team of researchers in California that gained attention last year for an aborted cloud-creation experiment on a retired aircraft carrier had been planning a much larger study of saltwater-spraying equipment to dim the sun's rays, Politico reported. The multimillion-dollar project would have produced clouds over a stretch of ocean larger than Puerto Rico. The documents— including funding requests, emails and texts— raise new questions about the billionaire-backed initiative that oversaw the 2024 test on San Francisco Bay. STORY CONTINUES BELOW THIS AD The records show the team had received some federal funding and sought access to US government ships, planes and funding. The researchers hoped to expand the project to multiple geographic locations, including off the west coasts of North America, Chile or south-central Africa. Alameda test was shut down after 20 minutes The initial experiment, led by the University of Washington's Marine Cloud Brightening Program, was intended to run for months but lasted only 20 minutes before Alameda city officials halted it, saying they had not been informed. 'Alameda was a stepping stone to something much larger, and there wasn't any engagement with local communities,' said Sikina Jinnah, an environmental studies professor at the University of California in Santa Cruz. University officials downplayed the scale of the proposed ocean test and said the program was focused on assessing whether cloud-making instruments could work in real-world conditions. 'The program does not 'recommend, support or develop plans for the use of marine cloud brightening to alter weather or climate,'' said Sarah Doherty, who leads the program. Controversy over solar geoengineering Solar geoengineering, also called solar radiation management, seeks to reduce global warming by reflecting sunlight away from Earth. It includes techniques such as releasing sulfate particles into the stratosphere or spraying saltwater aerosols over oceans. Critics warn that such efforts could disrupt weather patterns, affect farm yields and wildlife, and create a risk of 'termination shock' if the processes stop abruptly. Conspiracy theories have added to the backlash, with Rep. Marjorie Taylor Greene (R-Ga.) falsely linking geoengineering to deadly floods in Texas and introducing a bill to criminalize the technology. In Florida, Republican Gov. Ron DeSantis recently signed a law banning the release of chemicals into the atmosphere to affect the climate. More than 575 scientists have called for a global ban, saying the technology 'cannot be governed globally in a fair, inclusive, and effective manner.' Billionaire donors and funding sources The program's donors include cryptocurrency billionaire Chris Larsen, philanthropist Rachel Pritzker and venture capitalist Chris Sacca. Larsen said research into marine cloud brightening is needed because of questions about its effectiveness and risks. 'At a time when scientists are facing political attacks and drastic funding cuts, we need to complement a rapid energy transition with more research into a broad range of potential climate solutions,' he said in an email to E&E News. STORY CONTINUES BELOW THIS AD Quadrature Climate Foundation, linked to London-based hedge fund Quadrature Capital, has given nearly $11.9 million to SilverLining and $5 million to the University of Washington for the research. SilverLining reported more than $3.6 million in revenue in 2023. It has also received six-figure donations from charities linked to former New York Gov. Eliot Spitzer and Intel co-founder Gordon Moore.
The Hindu
a day ago
- The Hindu
Study recommends two half-dose combination of drugs in a single pill for good blood pressure control in Indians
With evidence lacking thus far for guiding optimal combination hypertension therapy in South Asian patients, a recent study has recommended half doses of two drugs in a single pill combination right from the start of treatment for hypertension. The paper, 'Comparison of dual therapies for hypertension treatment in India', published in the journal Nature Medicine, investigated the blood pressure (BP)-lowering efficacy and safety of three commonly-recommended antihypertensive combinations in a single pill in a multi-centre trial across 32 sites in India. Nearly 2,000 adults with uncontrolled or untreated hypertension were studied, and interventions included three single-pill dual combinations: Amlodipine + Perindopril, Perindopril + Indapamide and Amlodipine + Indapamide. All three combinations, in patients aged 30–79, delivered equivalent BP reductions and similar rates of BP control, researchers said. All combinations were equally safe and effective with high tolerability over six months, they wrote in the paper. 'It must be noted that we are not recommending a multi-drug regimen. Polypharmacy will only lead to discontinuation of treatment,' says Prabhakaran Dorairaj, principal investigator of the study, from the Centre for Chronic Disease Control, New Delhi. 'What we are recommending is to start with half doses of two drugs in a single pill combination. If BP control does not happen, then it is important to titrate to full doses. Despite this, if BP continues to be higher than 140/90, then additional drugs are to be added,' he explains. 'It is really astounding that we have been basing treatment on Western guidelines, so far,' Dr. Prabhakaran adds. This study tests the global guidelines for hypertension treatment among patients in India, since these combinations are already available here. These drugs work through multiple pathways and are synergistic, with low side effects, he says. 'Many physicians, even cardiologists, think that they should start with a low dose and then keep escalating it,' says Nagendra Boopathy, co-author and interventional cardiologist, Sri Ramachandra Medical Centre, Chennai. 'Even patients are reluctant to start on drugs, but these combinations we have tested are really effective in bringing down BP, and the side effects are minor,' he adds. The side effects observed during the trial included cough, swelling of feet and lower potassium in some subgroups, and not statistically significant. Dr. Prabhakaran adds, 'The biggest problem in India is poor control of hypertension. Only around 20% of individuals with hypertension are treated to target in urban areas, and it is even lower in rural areas. It is estimated that a 10 mm reduction in BP among people with hypertension can prevent 40% of strokes. A vibrant pharmaceutical industry, which makes these single combinations and pooled procurement via the public health system, should help drive down prices, making this a key strategy in the battle against hypertension.'
Time of India
3 days ago
- Time of India
Shocking discovery: Common stomach bacteria may be linked to 12 million cancer cases
A startling new study has revealed that a common stomach bacteria could be responsible for nearly 12 million cancer cases among people born within a single decade. The bacterium, Helicobacter pylori (H. pylori), is already known to be a major cause of ulcers and chronic inflammation, but this new analysis, published in Nature Medicine, ties it directly to 76% of projected stomach cancer cases in those born between 2008 and 2017. Researchers estimate that 15.6 million people from this cohort will develop stomach cancer in their lifetimes, and H. pylori will be responsible for the majority of those diagnoses. Experts are calling for urgent global action to detect and eliminate this bacterial threat before it's too late. Cancer risks tied to H. pylori infection often go unnoticed in early years H. pylori is a spiral-shaped bacterium that typically infects the stomach lining in childhood. While most people show no symptoms, it can cause long-term damage by leading to ulcers, inflammation, and, ultimately, cancer in some individuals. The bacteria is primarily transmitted through oral contact—such as kissing—or through exposure to contaminated vomit or stool. Despite its global presence, it often goes undiagnosed for years. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like TV providers are furious: this gadget gives you access to all channels Techno Mag Learn More Undo Chronic infections allow the bacteria to silently alter the stomach environment, increasing cancer risk over time. Cancer burden expected to rise, especially in Asia and Africa The study, led by researchers at the World Health Organization 's International Agency for Research on Cancer (IARC), analyzed global data from 185 countries. Their projections indicate that up to 11.9 million stomach cancer cases caused by H. pylori could be diagnosed by the year 2101, which is when the youngest individuals in the studied group turn 84. Asia will see the greatest burden with around 8 million cases, while Europe is expected to see nearly half a million. Alarmingly, sub-Saharan Africa—currently with relatively low incidence—may see a sixfold increase due to aging populations and demographic shifts. Early detection could prevent up to 75% of cases Although stomach cancer is difficult to treat in its later stages, it is largely preventable. Researchers urge governments to implement screening and treatment programs for H. pylori infections, especially in high-risk regions. Early detection and simple antibiotic regimens could dramatically reduce the future cancer burden. The study estimates that prevention efforts could avert up to three-quarters of projected cases. As Dr. Jin Young Park, one of the study's authors, emphasized: 'It is essential that health authorities make gastric cancer prevention a priority and accelerate efforts to control it.'
